PKU HealthCare Corp.,Ltd. (SZSE: 000788)
Health Care · Pharmaceuticals · CN
CN¥5.46
+1.49% today · -11.1% 1Y
PKU HealthCare Corp.,Ltd. (SZSE: 000788) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $485.12M and employs 789 people.
Over the last twelve months the share price has lost 11.1%, trading between 4.66 and 7.99.
Tweenvest scores PKU HealthCare Corp.,Ltd. across four factors: quality 82/100, value 45/100, growth 26/100, dividend 49/100. Its strongest factor is quality.
000788 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $485.12M
- Revenue (TTM)
- $143.12M
- P/E
- 85.06
- EPS
- 0.06
- Dividend yield
- 3.63%
- Beta (5Y)
- 0.15
- 52-week high
- CN¥7.99
- 52-week low
- CN¥4.66
- Avg volume (3M)
- —
- Shares outstanding
- 595.99M
- Employees
- 789
- Next earnings
- —
About PKU HealthCare Corp.,Ltd.
Operating within China, PKU HealthCare Corp.,Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of medicinal products. Its extensive portfolio encompasses a broad spectrum of therapeutic areas, offering medications for conditions such as cancer (anti-tumor, oncology), neuropsychiatric disorders, cardiovascular issues, immune system regulation (immunosuppressive), infections (antimicrobial), pain and fever (antipyretic and analgesic), digestive ailments, allergies, blood sugar management, mental health, and blood volume expansion. Founded in 1965, the company was initially known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. before officially rebranding to PKU HealthCare Corp.,Ltd. in November 2013. Its primary operations are based out of its headquarters in Chongqing, China.
- ISIN
- CNE0000008M0
- Founded
- 1993
- Listed since
- Jun 16, 1997
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Haisen Pharmaceutical Co., Ltd.SZSE: 001367 | $493.30M | CN¥22.01 | +2.37% |
| Hinova Pharmaceuticals Inc.SHSE: 688302 | $492.14M | CN¥33.34 | +1.37% |
| Arvinas, Inc.NasdaqGS: ARVN | $491.05M | $7.51 | +0.81% |
| Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim SirketiIBSE: GENIL | $485.30M | TL5.30 | -27.89% |
| Daewoong Co., Ltd.KOSE: A003090 | $478.81M | ₩15,340.00 | -3.46% |
| iX Biopharma Ltd.Catalist: 42C | $478.80M | S$0.56 | +2.75% |
| Myung In Pharmaceutical LTD.KOSE: A317450 | $473.20M | ₩43,650.00 | +3.93% |
| Dong-A Socio Holdings Co., Ltd.KOSE: A000640 | $472.72M | ₩94,600.00 | +2.16% |
Figures last refreshed Oct 4, 2026.